Phototoxic reactions in healthy volunteers following photodynamic therapy with methylaminolevulinate cream or with cream containing 5-aminolevulinic acid: A phase II, randomized study

Photodermatology Photoimmunology and Photomedicine

Volumn 25, Issue 5, 2009, Pages 270-275

  Steinbauer, Julia ^a   Schreml, Stephan ^a   Karrer, Sigrid ^a   Ackermann, Günther ^b   Babilas, Philipp ^a   Landthaler, Michael ^a   Szeimies, Rolf Markus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b BIOCAM GmbH   (Germany)

Author keywords

Aminolevulinic acid; Methylaminolevulinate; Pain; Photodynamic therapy; Phototoxicity

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; SUBSTANCE P;

ADULT; ANIMAL TISSUE; APPLICATION SITE HYPERPIGMENTATION; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DERMATITIS; DOUBLE BLIND PROCEDURE; ERYTHEMA; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN EXPERIMENT; IMMUNOPATHOLOGY; MALE; NONHUMAN; NORMAL HUMAN; PAIN; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; AREA UNDER CURVE; HUMANS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REFERENCE VALUES; SUBSTANCE P;

EID: 72749094247     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2009.00455.x     Document Type: Article

References (24)

1. Klein A, Babilas P, Karrer S, Landthaler M, Szeimies R.M. Photodynamic therapy in dermatology - an update 2008. J Dtsch Dermatol Ges 2008; 6: 839-846.
2. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006; 155: 1262-1269.
3. Babilas P, Landthaler M, Szeimies R.M. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
4. Foley P. Clinical efficiacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatol Treat 2003; 14 (Suppl. 3): 15-22.
5. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-1036.
6. Sandberg C, Stenquist B, Rosdahl I, Berne B, Svanberg K,Wennberg A.M. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408.
7. Thissen MRTM, Schroeter CA, Neumann H.A.M. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338-339.
8. Morton C.A. Methyl aminolevulinate actinic keratoses and Bowen's disease. Dermatol Clin 2007; 25: 81-87.
9. Morton C.A. Realizing the cosmetic potential of topical photodynamic therapy. J Cosmet Dermatol 2002; 1: 66-71.
10. Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77: 115- 121.
11. Morton CA, McKenna KE, Rhodes L.E. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-1266.
12. Wiegell SR, Stender IM, Na R, Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003; 139: 1173-1177.
13. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006; 5: 353-356.
14. Peng Q, Moan J, Warloe T, et al. Build-up of esterified aminolevulinic acid-derivate-induced porphyrin fluorescence in normal mouse skin. Photochem Photobiol B Biol 1996; 34: 95-96.
15. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-143.
16. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793-801.
17. Clark C, Dawe RS, Moseley H, Ferguson J, Ibbotson S.H. The characteristics of erythema induced by topical 5-aminollaevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed 2004; 20: 105-107.
18. Rud E, Gederaas O, Høgset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000; 71: 640-647.
19. Lynn B, YeW, Cotsell B. The actions of capsaicin applied topically to the skin of the rat on C-fibre afferents, antidromic vasodilatation and substance P levels. Br J Pharmacol 1992; 107: 400-406.
20. Goldman MP, Merial-Kieny C, Nocera T, Mery S. Comparative benefit of two thermal spring waters after photodynamic therapy procedure. J Cosmet Dermatol 2007; 6: 31-35.
21. Halldin CB, Paoli J, Sandberg C, Ericson MB, Wennberg A.M. Transcutaneous electrical nerve stimultion for pain relief during photodynamic therapy of actinic keratoses. Acta Derm Venereol 2008; 88: 311-313.
22. Wiegell SR, Skiveren J, Philipsen PA, Wulf H.C. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727-733.
23. Casas A, Fukuda H, Di Venosa G, Batlle A. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 2001; 85: 279-284.
24. Angell-Petersen E, Christensen C, Müller CR, Warloe T.Phototoxic reaction and porphyrin fluorescene in skin after topical application of methyl aminolaevulinateBr J Dermatol 2007; 156: 301-307.